首頁 > 市場調查報告書 > 醫療設備

體外診斷

膽固醇檢測市場規模、佔有率和成長分析（按產品、檢測方法、年齡層、應用、分銷管道、服務提供者和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1902718

膽固醇檢測市場規模、佔有率和成長分析（按產品、檢測方法、年齡層、應用、分銷管道、服務提供者和地區分類）—產業預測（2026-2033 年）

Cholesterol Test Market Size, Share, and Growth Analysis, By Product (Testing Kits, Testing Strips), By Test, By Age Group, By Application, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 218 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球膽固醇檢測市場規模將達到 79.9 億美元，到 2025 年將成長至 86.6 億美元，到 2033 年將成長至 165.1 億美元，預測期（2026-2033 年）的複合年成長率為 8.4%。

全球膽固醇檢測市場正經歷顯著成長，其主要促進因素是與久坐生活方式和不健康飲食習慣相關的心血管疾病盛行率不斷上升。人們對預防性醫療保健的日益重視以及對定期篩檢重要性的認知不斷提高，推動了對膽固醇管理解決方案的需求。創新照護現場設備和家用檢測套組等技術進步，進一步提升了膽固醇測量的可近性和準確性。此外，人口老化加劇，老年人更容易受到高膽固醇的影響，這也顯著增加了對檢測服務的需求。儘管仍存在一些挑戰，例如診斷檢查室短缺和法規環境嚴格，但投資醫療基礎設施和持續技術創新仍蘊藏著機會。總而言之，膽固醇檢測產業具有巨大的擴張和創新潛力，凸顯了其在心血管健康管理中的關鍵作用。

全球膽固醇檢測市場促進因素

心血管疾病（包括心臟病和中風）的流行仍然是全球範圍內導致發病率和死亡率的主要原因。這種日益嚴重的擔憂凸顯了膽固醇檢測在心血管風險評估中的重要性，進而推動了對膽固醇檢測產品和服務的需求。隨著個人和醫療保健提供者越來越認知到膽固醇水平與心臟健康之間的關聯，由於在預防和管理心血管疾病方面對有效評估工具的持續需求，膽固醇檢測市場也相應擴大。這一趨勢證實了膽固醇檢測在現代醫學中的關鍵作用。

限制全球膽固醇檢測市場的因素

膽固醇檢測費用高昂，對資源匱乏和用戶族群而言尤其如此，構成重大挑戰。高昂的檢測費用阻礙了人們定期進行膽固醇檢測，尤其是在低收入族群。這種經濟障礙不僅限制了人們獲得基本醫療服務的機會，也阻礙了有效的膽固醇監測和管理，可能導致更差的健康結果。解決這些與費用相關的問題對於提高檢測率和促進弱勢群體心血管疾病的預防至關重要。

全球膽固醇檢測市場趨勢

全球膽固醇檢測市場正經歷著向先進檢測技術的顯著轉變，其特點是不斷創新，以提高檢測的準確性和便利性。關鍵發展包括就地檢驗設備、非侵入性調查方法以及旨在簡化膽固醇測量流程的高靈敏度檢測技術。此外，這些檢測解決方案與數位健康平台、電子健康記錄(EHR) 和遠端醫療系統的整合日益普及，促進了遠端監測和全面的資料管理。這種整合不僅簡化了病患參與流程，也增強了不同醫療機構的膽固醇管理流程，體現了心血管健康監測領域的變革性方法。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Abbott Laboratories（USA）
F. Hoffmann-La Roche Ltd.（Switzerland）
Siemens Healthineers AG（Germany）
Thermo Fisher Scientific Inc.（USA）
Danaher Corporation（USA）
PerkinElmer, Inc.（USA）
Bio-Rad Laboratories, Inc.（USA）
Randox Laboratories Ltd.（UK）
Eurofins Scientific（Luxembourg）
Novartis AG（Switzerland）
Merck KGaA（Germany）
Beckman Coulter Inc.（USA）
Boston Heart Diagnostics Corporation（USA）
Quest Diagnostics Incorporated（USA）
Laboratory Corporation of America Holdings（Labcorp）（USA）
QuidelOrtho Corporation（USA）
Helena Laboratories Corporation（USA）
Sekisui Chemical Co., Ltd.（Japan）
Sinocare Inc.（China）

結論與建議

簡介目錄

Product Code: SQMIG35A2894

Global Cholesterol Test Market size was valued at USD 7.99 Billion in 2024 and is poised to grow from USD 8.66 Billion in 2025 to USD 16.51 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).

The global cholesterol testing market is witnessing substantial growth, propelled by rising cardiovascular disease prevalence linked to sedentary lifestyles and unhealthy dietary choices. Increasing awareness of preventive healthcare and the importance of regular screenings enhances demand for cholesterol management solutions. Technological advancements, like innovative point-of-care devices and home testing kits, further facilitate accessibility and accuracy of cholesterol measurements. Additionally, the aging population, more susceptible to high cholesterol levels, significantly drives the need for testing services. While challenges such as a shortage of diagnostic labs and stringent regulatory environments persist, opportunities lie in investment in healthcare infrastructure and ongoing technological innovations. Overall, the cholesterol testing sector presents vast prospects for expansion and innovation, underscoring its critical role in managing cardiovascular health.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cholesterol Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cholesterol Test Market Segments Analysis

Global Cholesterol Test Market is segmented by Product, Test, Age Group, Application, Distribution Channel, Service Provider and region. Based on Product, the market is segmented into Testing Kits, Testing Strips and Others. Based on Test, the market is segmented into Total Cholesterol Tests, High Density Lipoprotein (HDL) Cholesterol Tests, Low Density Lipoprotein (LDL) Cholesterol Tests, Triglyceride Tests and Others. Based on Age Group, the market is segmented into Geriatric, Adult and Pediatric. Based on Application, the market is segmented into Cardiovascular Diseases, Diabetes, Obesity, Hyperlipidemia and Others. Based on Distribution Channel, the market is segmented into Over the Counter and Prescription Based. Based on Service Provider, the market is segmented into Hospitals and Clinics, Diagnostic Laboratories, Ambulatory Care Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cholesterol Test Market

The prevalence of cardiovascular diseases, such as heart disease and stroke, continues to be a significant source of illness and death around the globe. This growing concern emphasizes the importance of cholesterol testing in evaluating cardiovascular risk, which in turn fuels the demand for cholesterol testing products and services. As individuals and healthcare providers increasingly recognize the correlation between cholesterol levels and heart health, the market for cholesterol tests expands accordingly, driven by the ongoing necessity for effective assessment tools in the prevention and management of cardiovascular conditions. This trend underscores the critical role of cholesterol testing in modern healthcare.

Restraints in the Global Cholesterol Test Market

The expense associated with cholesterol testing presents a considerable challenge, particularly in areas with constrained healthcare resources or among populations without insurance coverage. Elevated testing costs can discourage individuals from participating in regular cholesterol screenings, which is especially true for those belonging to lower socioeconomic backgrounds. This financial barrier not only limits access to essential health services but also hinders efforts to monitor and manage cholesterol levels effectively, potentially leading to detrimental health outcomes. Addressing these cost-related issues is crucial to improving screening rates and fostering better overall cardiovascular health within vulnerable communities.

Market Trends of the Global Cholesterol Test Market

The Global Cholesterol Test market is experiencing a notable shift towards advanced testing technologies, characterized by innovations that enhance accuracy and accessibility. Key developments include point-of-care testing devices, non-invasive testing methodologies, and high-sensitivity assays, all designed to improve efficiency in cholesterol measurement. Additionally, the integration of these testing solutions with digital health platforms, electronic health records (EHRs), and telemedicine systems is increasingly prevalent, facilitating remote monitoring and comprehensive data management. This integration not only streamlines patient engagement but also enhances cholesterol management processes within diverse healthcare environments, reflecting a transformative approach to cardiovascular health monitoring.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Cholesterol Test Market Size by Product & CAGR (2026-2033)

Market Overview
Testing Kits
Testing Strips
Others

Global Cholesterol Test Market Size by Test & CAGR (2026-2033)

Market Overview
Total Cholesterol Tests
High Density Lipoprotein (HDL) Cholesterol Tests
Low Density Lipoprotein (LDL) Cholesterol Tests
Triglyceride Tests
Others

Global Cholesterol Test Market Size by Age Group & CAGR (2026-2033)

Market Overview
Geriatric
Adult
Pediatric

Global Cholesterol Test Market Size by Application & CAGR (2026-2033)

Market Overview
Cardiovascular Diseases
Diabetes
Obesity
Hyperlipidemia
Others

Global Cholesterol Test Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Over the Counter
Prescription Based

Global Cholesterol Test Market Size by Service Provider & CAGR (2026-2033)

Market Overview
Hospitals and Clinics
Diagnostic Laboratories
Ambulatory Care Centers
Others

Global Cholesterol Test Market Size & CAGR (2026-2033)

North America (Product, Test, Age Group, Application, Distribution Channel, Service Provider)
- US
- Canada
Europe (Product, Test, Age Group, Application, Distribution Channel, Service Provider)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Test, Age Group, Application, Distribution Channel, Service Provider)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Test, Age Group, Application, Distribution Channel, Service Provider)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Test, Age Group, Application, Distribution Channel, Service Provider)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Heart Diagnostics Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings (Labcorp) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QuidelOrtho Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Helena Laboratories Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sekisui Chemical Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sinocare Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments